LIF antibody (C-Term)
Quick Overview for LIF antibody (C-Term) (ABIN8005864)
Target
See all LIF AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- C-Term
-
Purpose
- Anti-Leukemia inhibitory factor LIF Antibody
-
Specificity
- No cross reactivity with other proteins.
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins
-
Predicted Reactivity
- identical to the related rat sequence.
-
Characteristics
- Anti-Leukemia inhibitory factor LIF Antibody. Tested in WB applications. This antibody reacts with Mouse, Rat.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- A synthetic peptide corresponding to a sequence at the C-terminus of mouse LIF, identical to the related rat sequence.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blot, 0.1-0.5 μg/mL, Mouse, Rat
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Concentration
- 500 μg/mL
-
Buffer
- Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
-
Preservative
- Sodium azide, Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate) and Sodium azide: POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles. -
Expiry Date
- 12 months
-
-
- LIF (Leukemia Inhibitory Factor (LIF))
-
Alternative Name
- LIF
-
Background
-
Background: LIF is a pleiotropic cytokine produced at the maternal-fetal interface which has been shown to play an essential role in implantation in mice. LIF is produced in high amounts by the human endometrium and the trophoblast itself, and LIF receptors are present on cytotrophoblast cells. LIF could, thus, play a role in modulating HLA-G production and immune tolerance at the maternal-fetal interface. The gene maps to 22q11-q12.2, between the Philadelphia translocation BCR gene and the breakpoint of the translocation in cell line GM2324 at 22q12.2.
Gene Full Name: leukemia inhibitory factor
Sequence Similarities: Belongs to the tumor necrosis factor family.
-
Molecular Weight
- 40 kDa
-
Gene ID
- 16878
-
UniProt
- P09056
-
Pathways
- JAK-STAT Signaling, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Stem Cell Maintenance, Growth Factor Binding
Target
-